Konstantinos L. Bourantas

University Hospital of Ioannina — Greece

Medicine · Health Sciences

27h-index2.5kcitations124works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hemoglobinopathies and Related Disorders(27), Multiple Myeloma Research and Treatments(18), Myeloproliferative Neoplasms: Diagnosis and Treatment(17), Acute Myeloid Leukemia Research(14), Chronic Lymphocytic Leukemia Research(14)

Publications119 total

Immunohistochemical expression of cell cycle proteins in multiple myeloma
Leukemia & lymphoma/Leukemia and lymphoma·2015
Front & Back Matter
Acta Haematologica·2012
Determinants of Pulmonary Hypertension in Patients with Beta-Thalassemia Major and Normal Ventricular Function
Acta Haematologica·2012· 28 cited
Rheumatoid arthritis in patients with hemoglobinopathies
Rheumatology International·2011· 14 cited
Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigenetic interactions
Annals of Hematology·2011· 53 citedOpen Access
The Prolyl-3-Hydroxylase Leprecan Like 1 (Leprel1) Is a Selective Target for Epigenetic Silencing In Multiple Myeloma.
Blood·2010
Study of specific genetic and epigenetic variables in multiple myeloma
Leukemia & lymphoma/Leukemia and lymphoma·2010· 31 cited
Brucellosis-Induced Autoimmune Hemolytic Anemia Treated with Rituximab
Annals of Pharmacotherapy·2010· 15 cited
Hypoxia and activated VEGF/receptor pathway in multiple myeloma.
PubMed·2010· 68 cited
DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma
British Journal of Cancer·2010· 33 citedOpen Access
BIK (Bcl2-Interacting Killer) CpG methylation status as a potential predictive biomarker of relapsed/refractory multiple myeloma disease.
Journal of Clinical Oncology·2010· 1 cited
Thrombophilic risk factors in the pathogenesis of non-arteritic anterior ischemic optic neuropathy patients
Graefe s Archive for Clinical and Experimental Ophthalmology·2010· 18 cited
Acknowledgement to Referees
Acta Haematologica·2010Open Access
Subject Index Vol. 124, 2010
Acta Haematologica·2010Open Access
Serum Adipocytokine and Vascular Inflammation Marker Levels in Beta-Thalassaemia Major Patients
Acta Haematologica·2010· 24 cited
BIK (Bcl2-Interacting Killer) CpG Methylation Status in Multiple Myeloma Patients: a Potential Predictor of Relapsed/Refractory Disease.
Blood·2009
The prolyl‐hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia
European Journal Of Haematology·2009· 55 citedOpen Access
CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes
Leukemia Research·2009· 162 cited
von Hippel–Lindau Methylation Status in Patients with Multiple Myeloma: A Potential Predictive Factor for the Development of Bone Disease
Clinical Lymphoma & Myeloma·2009· 34 cited
Snk/Plk2 CpG methylation in patients with multiple myeloma
Journal of Clinical Oncology·2009
page 1 of 6Next →

Frequent Co-authors

Eleftheria Hatzimichael(19), Stavroula Tsiara(9), Leonidas Benetatos(8), Aristeidis Chaidos(8), Alexandros Makis(8), Aggeliki Dasoula(6), Justin Stebbing(6), George Dranitsaris(5), Tim Crook(5), Leonidas Christou(5), Eleni Kapsali(5), Ioannis Georgiou(4), K Panteli(4), Argiris Symeonidis(4), Anestis Mavridis(4), Nelofer Syed(4), Maria Bai(3), Meletios Α. Dimopoulos(3), Konstantinos Zervas(3), Dimitra Gika(3)